BeOne Medicines (ONC) Enterprise Value: 2015-2025
Historic Enterprise Value for BeOne Medicines (ONC) over the last 11 years, with Sep 2025 value amounting to $33.4 billion.
- BeOne Medicines' Enterprise Value rose 58.36% to $33.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $25.5 billion, marking a year-over-year increase of 103.42%. This contributed to the annual value of $17.1 billion for FY2024, which is 8.79% up from last year.
- BeOne Medicines' Enterprise Value amounted to $33.4 billion in Q3 2025, which was up 43.10% from $23.4 billion recorded in Q2 2025.
- BeOne Medicines' Enterprise Value's 5-year high stood at $33.4 billion during Q3 2025, with a 5-year trough of $8.9 billion in Q3 2022.
- In the last 3 years, BeOne Medicines' Enterprise Value had a median value of $17.1 billion in 2024 and averaged $19.3 billion.
- As far as peak fluctuations go, BeOne Medicines' Enterprise Value soared by 337.68% in 2021, and later crashed by 70.15% in 2022.
- BeOne Medicines' Enterprise Value (Quarterly) stood at $18.8 billion in 2021, then declined by 2.67% to $18.3 billion in 2022, then fell by 14.27% to $15.7 billion in 2023, then climbed by 8.79% to $17.1 billion in 2024, then spiked by 58.36% to $33.4 billion in 2025.
- Its Enterprise Value was $33.4 billion in Q3 2025, compared to $23.4 billion in Q2 2025 and $26.5 billion in Q1 2025.